Immunotherapies hold enormous promise for treating cancers of various types, but the bad news is that while many patients may initially respond many will also become resistant. Valsamo Anagnostou, a cancer researcher at Johns Hopkins, is looking at tumor specific …

Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports Read More »